Events & Webinars
|Subcutaneous Insulin Use in Adults: Addressing Risks and Optimizing Safety
Wednesday, December 6, 2017 - 11:30am-1:00pm ET
Insulin therapy, while essential to the health of millions of patients, continues to be a leading cause of serious patient harm when used in error. This symposium will provide up-to-date information on the top insulin safety issues facing practitioners and an overview of ISMP’s newly-released national guidelines for safe subcutaneous insulin use. Expert speakers will discuss some of the unique challenges involved in managing complex insulin therapy across the continuum of care, including the use of concentrated insulins, insulin vials, and pens.
The target audience for this activity includes pharmacists and pharmacy technicians in health-system settings. At the completion of this symposium, the participant will be able to:
10:45am - Doors open
Topics and Faculty
Introduction and Overview
Pharmacists and Pharmacy Technicians
This CE activity is jointly provided by ProCE, Inc. and the Institute for Safe Medication Practices (ISMP). ProCE is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. ACPE Universal Activity Number 0221-9999-17-413-L05-P/T has been assigned to this knowledge-based live CE activity (initial release date December 6, 2017). This CE activity is approved for 1.5 contact hours (0.15 CEUs) in states that recognize ACPE providers. This CE activity is provided at no cost to participants. Successful completion of the online post-test and evaluation at www.ProCE.com no later than January 5, 2018 is required to receive CE credit. CE credit will be automatically uploaded to NABP/CPE Monitor upon completion of the post-test and evaluation. No partial credit will be given.
It is the policy of ProCE, Inc. to ensure balance, independence, objectivity and scientific rigor in all of its continuing education activities. Faculty must disclose to participants any significant financial interest or affiliation with companies that manufacture or market products discussed during their presentation. Conflict of interest disclosures are required of all faculty and shall be provided to all participants at the conference.
This symposium is funded through an educational grant from Lilly and Novo Nordisk.